Corbus Pharmaceuticals Holdings (CRBP) Research & Development (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) posted Research & Development of $20.86 million for Q3 2025, up 93.0% from $10.81 million a year earlier and up 37.4% from the prior quarter.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Research & Development (2013 - 2025) Analysis & Trends
For the trailing twelve months through Sep 30, 2025, Research & Development at Corbus Pharmaceuticals Holdings was $60.48 million, up 98.8% year-over-year; for FY2024, it came in at $32.22 million, up 3.4% from FY2023.
- Annual Research & Development shows a five-year compound annual growth rate of -18.5% (FY2019 to FY2024).
- In prior years, Corbus Pharmaceuticals Holdings' Research & Development was $31.17 million in FY2023 (+93.1%), $16.14 million in FY2022 (-55.7%), $36.45 million in FY2021 (-62.9%) and $98.27 million in FY2020 (+9.7%).
- The Q3 2025 figure stands as the highest quarterly Research & Development since Q3 2020.
- On a year-over-year basis, Research & Development has increased in each of the last six quarters, with growth averaging 61.6% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q1 2023, with growth of 307.4%; the weakest was Q4 2021, with a decline of 97.6%.
- According to Business Quant data, Research & Development for the three prior quarters was $15.19 million (Q2 2025), $15.64 million (Q1 2025) and $8.79 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Corbus Pharmaceuticals Holdings | 52.74 Mn | -463.89 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 20.86 Mn |
| Jun 30, 2025 | 15.19 Mn |
| Mar 31, 2025 | 15.64 Mn |
| Dec 31, 2024 | 8.79 Mn |
| Sep 30, 2024 | 10.81 Mn |
| Jun 30, 2024 | 6.87 Mn |
| Mar 31, 2024 | 5.76 Mn |
| Dec 31, 2023 | 6.98 Mn |
| Sep 30, 2023 | 6.55 Mn |
| Jun 30, 2023 | 4.25 Mn |
| Mar 31, 2023 | 13.39 Mn |
| Dec 31, 2022 | 6.24 Mn |
| Sep 30, 2022 | 4.11 Mn |
| Jun 30, 2022 | 2.50 Mn |
| Mar 31, 2022 | 3.29 Mn |
| Dec 31, 2021 | 380,000.00 |
| Sep 30, 2021 | 8.70 Mn |
| Jun 30, 2021 | 11.27 Mn |
| Mar 31, 2021 | 10.72 Mn |
| Dec 31, 2020 | 16.11 Mn |
API Access
Corbus Pharmaceuticals Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();